These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21176891)

  • 1. Human liver peroxisomal alanine:glyoxylate aminotransferase: characterization of the two allelic forms and their pathogenic variants.
    Cellini B; Montioli R; Voltattorni CB
    Biochim Biophys Acta; 2011 Nov; 1814(11):1577-84. PubMed ID: 21176891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Insight into the Synergism between the Minor Allele of Human Liver Peroxisomal Alanine:Glyoxylate Aminotransferase and the F152I Mutation.
    Cellini B; Montioli R; Paiardini A; Lorenzetto A; Voltattorni CB
    J Biol Chem; 2009 Mar; 284(13):8349-58. PubMed ID: 19155213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human liver peroxisomal alanine:glyoxylate aminotransferase: Different stability under chemical stress of the major allele, the minor allele, and its pathogenic G170R variant.
    Cellini B; Lorenzetto A; Montioli R; Oppici E; Voltattorni CB
    Biochimie; 2010 Dec; 92(12):1801-11. PubMed ID: 20713123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Misfolding caused by the pathogenic mutation G47R on the minor allele of alanine:glyoxylate aminotransferase and chaperoning activity of pyridoxine.
    Montioli R; Oppici E; Dindo M; Roncador A; Gotte G; Cellini B; Borri Voltattorni C
    Biochim Biophys Acta; 2015 Oct; 1854(10 Pt A):1280-9. PubMed ID: 26149463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of human alanine:glyoxylate aminotransferase in Escherichia coli: renaturation from guanidine-HCl and affinity for pyridoxal phosphate co-factor.
    Coulter-Mackie MB; Lian Q; Wong SG
    Protein Expr Purif; 2005 May; 41(1):18-26. PubMed ID: 15802217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular defects of the glycine 41 variants of alanine glyoxylate aminotransferase associated with primary hyperoxaluria type I.
    Cellini B; Montioli R; Paiardini A; Lorenzetto A; Maset F; Bellini T; Oppici E; Voltattorni CB
    Proc Natl Acad Sci U S A; 2010 Feb; 107(7):2896-901. PubMed ID: 20133649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver peroxisomal alanine:glyoxylate aminotransferase and the effects of mutations associated with Primary Hyperoxaluria Type I: An overview.
    Oppici E; Montioli R; Cellini B
    Biochim Biophys Acta; 2015 Sep; 1854(9):1212-9. PubMed ID: 25620715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human wild-type alanine:glyoxylate aminotransferase and its naturally occurring G82E variant: functional properties and physiological implications.
    Cellini B; Bertoldi M; Montioli R; Paiardini A; Borri Voltattorni C
    Biochem J; 2007 Nov; 408(1):39-50. PubMed ID: 17696873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional synergism between the most common polymorphism in human alanine:glyoxylate aminotransferase and four of the most common disease-causing mutations.
    Lumb MJ; Danpure CJ
    J Biol Chem; 2000 Nov; 275(46):36415-22. PubMed ID: 10960483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyridoxamine and pyridoxal are more effective than pyridoxine in rescuing folding-defective variants of human alanine:glyoxylate aminotransferase causing primary hyperoxaluria type I.
    Oppici E; Fargue S; Reid ES; Mills PB; Clayton PT; Danpure CJ; Cellini B
    Hum Mol Genet; 2015 Oct; 24(19):5500-11. PubMed ID: 26199318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gly161 mutations associated with Primary Hyperoxaluria Type I induce the cytosolic aggregation and the intracellular degradation of the apo-form of alanine:glyoxylate aminotransferase.
    Oppici E; Roncador A; Montioli R; Bianconi S; Cellini B
    Biochim Biophys Acta; 2013 Dec; 1832(12):2277-88. PubMed ID: 24055001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular insights into primary hyperoxaluria type 1 pathogenesis.
    Cellini B; Oppici E; Paiardini A; Montioli R
    Front Biosci (Landmark Ed); 2012 Jan; 17(2):621-34. PubMed ID: 22201765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of interface mutations on the dimerization of alanine glyoxylate aminotransferase and implications in the mistargeting of the pathogenic variants F152I and I244T.
    Dindo M; Montioli R; Busato M; Giorgetti A; Cellini B; Borri Voltattorni C
    Biochimie; 2016 Dec; 131():137-148. PubMed ID: 27720751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical analyses are instrumental in identifying the impact of mutations on holo and/or apo-forms and on the region(s) of alanine:glyoxylate aminotransferase variants associated with primary hyperoxaluria type I.
    Oppici E; Montioli R; Lorenzetto A; Bianconi S; Borri Voltattorni C; Cellini B
    Mol Genet Metab; 2012 Jan; 105(1):132-40. PubMed ID: 22018727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consequences of missense mutations for dimerization and turnover of alanine:glyoxylate aminotransferase: study of a spectrum of mutations.
    Coulter-Mackie MB; Lian Q
    Mol Genet Metab; 2006 Dec; 89(4):349-59. PubMed ID: 16971151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S81L and G170R mutations causing Primary Hyperoxaluria type I in homozygosis and heterozygosis: an example of positive interallelic complementation.
    Montioli R; Roncador A; Oppici E; Mandrile G; Giachino DF; Cellini B; Borri Voltattorni C
    Hum Mol Genet; 2014 Nov; 23(22):5998-6007. PubMed ID: 24990153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of alanine:glyoxylate aminotransferase and the relationship between genotype and enzymatic phenotype in primary hyperoxaluria type 1.
    Zhang X; Roe SM; Hou Y; Bartlam M; Rao Z; Pearl LH; Danpure CJ
    J Mol Biol; 2003 Aug; 331(3):643-52. PubMed ID: 12899834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of alanine:glyoxylate aminotransferase variants and pyridoxine sensitivity on oxalate metabolism in a cell-based cytotoxicity assay.
    Fargue S; Knight J; Holmes RP; Rumsby G; Danpure CJ
    Biochim Biophys Acta; 2016 Jun; 1862(6):1055-62. PubMed ID: 26854734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Chaperoning Activity of Amino-oxyacetic Acid on Folding-Defective Variants of Human Alanine:Glyoxylate Aminotransferase Causing Primary Hyperoxaluria Type I.
    Oppici E; Montioli R; Dindo M; Maccari L; Porcari V; Lorenzetto A; Chellini S; Voltattorni CB; Cellini B
    ACS Chem Biol; 2015 Oct; 10(10):2227-36. PubMed ID: 26161999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of low native state kinetic stability and interaction of partially unfolded states with molecular chaperones in the mitochondrial protein mistargeting associated with primary hyperoxaluria.
    Pey AL; Salido E; Sanchez-Ruiz JM
    Amino Acids; 2011 Nov; 41(5):1233-45. PubMed ID: 21103899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.